Kwality Pharmaceuticals Secures Hungarian EU-GMP Approval for Cephalosporin and Oncology Units
Kwality Pharmaceuticals Ltd 路 Others (Uncategorized) 路 04 Nov 2026, 6:29 pm
Kwality Pharmaceuticals Secures Hungarian EU-GMP Approval for Cephalosporin and Oncology Units Kwality Pharmaceuticals Ltd. has secured EU-GMP approval from Hungary for its Cephalosporin and Oncology manufacturing facilities, complementing its existing EU-GMP certification from Bulgaria. This regulatory milestone significantly broadens the company鈥檚 certified capacity across specialized pharmaceutical segments and strengthens its competitive position in highly regulated, high-value global markets. The approval is expected to drive international business growth by unlocking new licensing opportunities and accelerating foreign product registrations.
Original exchange filing (PDF)
More announcements from Kwality Pharmaceuticals Ltd
- Transcript of Earnings Conference Call - Q2FY2027 路 16 Nov 2026
- Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015 - Recording of Investor/ Analyst Earnings Call held on November 13, 2026 路 14 Nov 2026
- Intimation under Regulation 30 of the SEBI(LODR), 2015 -Recording of Investor/ Analyst Earnings Call held on September 13, 2026 路 14 Nov 2026
- Investor Presentation for the quarter and half year ended unaudited financial results for 30-09-2026 路 12 Nov 2026
- Appointment of new Statutory Auditors 路 12 Nov 2026
- Resignation of Statutory Auditor 路 12 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026. 路 12 Nov 2026
- Approval of Unaudited Financial Results for the quarter and half year ended 30-09-2026 路 12 Nov 2026
